References
- Olson-Chen, C. & Seligman, N.S. (2016). Hypertensive Emergencies in Pregnancy. Crit. Care. Clin., 32(1), 29–41.2660044210.1016/j.ccc.2015.08.006
- Lo, J.O., Mission, J.F. & Caughey, A.B. (2013). Hypertensive disease of pregnancy and maternal mortality. Curr. Opin. Obstet. Gynecol., 25(2), 124–32.10.1097/GCO.0b013e32835e0ef523403779
- American College of Obstetricians and Gynecologists. (2013). Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet. Gynecol., 122(5), 1122–31.
- Tranquilli, A.L., Dekker, G., Magee, L., Roberts, J., Sibai, B.M., Steyn, W., Zeeman, G.G. & Brown, M.A. (2014). The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP. Pregnancy. Hypertens., 4(2), 97–104.2610441710.1016/j.preghy.2014.02.001
- Sawchuck, D.J. & Wittmann, B.K. (2014). Pre-eclampsia renamed and reframed: Intra-abdominal hypertension in pregnancy. Med. Hypotheses., 83(5), 619–32.10.1016/j.mehy.2014.08.00125189485
- Cunningham, M.W. Jr & LaMarca, B.D. (2018). The Risk of Cardiovascular Disease, End-Stage Renal Disease, and Stroke in Post-Partum Women and their Fetuses after a Hypertensive Pregnancy. Am. J. Physiol. Regul. Integr. Comp. Physiol., DOI: 10.1152/ajpregu.00218.2017.
- Dildy, G.A. 3rd, Belfort, M.A. & Smulian, J.C. (2007). Preeclampsia recurrence and prevention. Semin. Perinatol., 31(3), 135–41.10.1053/j.semperi.2007.03.00517531895
- Duckitt, K. & Harrington, D. (2005). Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ., 330(7491), 565.1574385610.1136/bmj.38380.674340.E0
- Mayer-Pickel, K., Stern, C., Eberhard, K., Lang, U., Obermayer-Pietsch, B. & Cervar-Zivkovic, M. (2018). Angiogenic factors in pregnancies of women with antiphospholipid syndrome and systemic lupus erythematosus. J. Reprod. Immunol., 127, 19–23.10.1016/j.jri.2018.04.00229689494
- Redman, C.W. (2011). Preeclampsia: a multi-stress disorder. Rev. Med. Interne., 32 Suppl 1, S41–4.2153002010.1016/j.revmed.2011.03.331
- Young, B.C., Levine, R.J. & Karumanchi, S.A. (2010). Pathogenesis of preeclampsia. Annu. Rev. Pathol., 5, 173–92.10.1146/annurev-pathol-121808-10214920078220
- Velauthar, L., Plana, M.N., Kalidindi, M., Zamora, J., Thilaganathan, B., Illanes, S.E., Khan, K.S., Aquilina, J. and Thangaratinam S. (2014). First-trimester uterine artery Doppler and adverse pregnancy outcome: a meta-analysis involving 55,974 women. Ultrasound. Obstet. Gynecol., 43(5), 500–7.10.1002/uog.1327524339044
- Khong, S.L., Kane, S.C., Brennecke, S.P. & da Silva Costa, F. (2015). First-trimester uterine artery Doppler analysis in the prediction of later pregnancy complications. Dis. Markers., 2015, 679730.25972623
- Sánchez-Aranguren, L.C., Espinosa-González, C.T., González-Ortiz, L.M., Sanabria-Barrera, S.M., Riaño-Medina, C.E., Nuñez, A.F., Ahmed, A., Vasquez-Vivar, J. & López, M. (2018). Soluble Fms-Like Tyrosine Kinase-1 Alters Cellular Metabolism and Mitochondrial Bioenergetics in Preeclampsia. Front. Physiol., 9, 83.2956387710.3389/fphys.2018.00083
- Levine, R.J., Lam, C., Qian, C., Yu, K.F., Maynard, S.E., Sachs, B.P., Sibai, B.M., Epstein, F.H., Romero, R., Thadhani, R. & Karumanchi, S.A. (2006). CPEP Study Group. Soluble endoglin and other circulating anti-angiogenic factors in preeclampsia. N. Engl. J. Med., 355(10), 992–1005.10.1056/NEJMoa055352
- Petsas, G., Jeschke, U., Richter, D.U., Minas, V., Hammer, A., Kalantaridou, S., Toth, B., Tsatsanis, C., Friese, K. & Makrigiannakis, A. (2012). Aberrant expression of corticotropin-releasing hormone in pre-eclampsia induces expression of FasL in maternal macrophages and extravillous trophoblast apoptosis. Mol. Hum. Reprod., 18(11), 535–45.10.1093/molehr/gas02722763913
- De Villiers, C.P., Hedley, P.L., Placing, S., Wøjdemann, K.R., Shalmi, A.C., Carlsen, A.L., Rode, L., Sundberg, K., Tabor, A. & Christiansen, M. (2017). Placental protein-13 (PP13) in combination with PAPP-A and free leptin index (fLI) in first trimester maternal serum screening for severe and early preeclampsia. Clin. Chem. Lab. Med., 56(1), 65–74.28704180
- Fleischer, A., Schulman, H., Farmakides, G., Bracero, L., Grunfeld, L., Rochelson, B. & Koenigsberg M. (1986). Uterine artery Doppler velocimetry in pregnant women with hypertension. Am J Obstet Gynecol., 154(4), 806–13.10.1016/0002-9378(86)90462-X3515946
- Sharma, S., Singh, S., Gujral, U., Oberoi, U. & Kaur, R. (2011). Uterine Artery Notching on Color Doppler Ultrasound and Roll over Test in Prediction of Pregnancy Induced Hypertension. J. Obstet. Gynaecol. India., 61(6), 649–51.10.1007/s13224-011-0110-z23204683
- Konje, J.C., Kaufmann, P., Bell, S.C. & Taylor, D.J. (2001). A longitudinal study of quantitative uterine blood flow with the use of color power angiography in appropriate for gestational age pregnancies. Am. J. Obstet. Gynecol., 185(3), 608–13.1156878610.1067/mob.2001.117187
- Sharma, N., Jayashree, K. & Nadhamuni, K. (2018). Maternal history and uterine artery wave form in the prediction of early-onset and late-onset preeclampsia: A cohort study. Int. J. Reprod. Biomed. (Yazd)., 16(2), 109–14.29675495
- Pedroso, M.A., Palmer, K.R., Hodges, R.J., Costa, F.D.S. & Rolnik, D.L. (2018). Uterine Artery Doppler in Screening for Preeclampsia and Fetal Growth Restriction. Rev. Bras. Ginecol. Obstet., 40(5), 287–93.2991354410.1055/s-0038-1660777
- Tan, M.Y., Syngelaki, A., Poon, L.C., Rolnik, D.L., O’Gorman, N., Delgado, J.L., Akolekar, R., Konstantinidou, L., Tsavdaridou, M., Galeva, S., Ajdacka, U., Molina, F.S., Persico, N., Jani, J.C., Plasencia, W., Greco, E., Papaioannou, G., Wright, A., Wright, D. & Nicolaides, K.H. (2018). Screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks’ gestation. Ultrasound. Obstet. Gynecol., DOI: 10.1002/uog.19112
- Abdel Razik, M., Mostafa, A., Taha, S. & Salah, A. (2018). Combined Doppler ultrasound and platelet indices for prediction of preeclampsia in high-risk pregnancies. J. Matern. Fetal. Neonatal. Med., DOI: 10.1080/14767058.2018.148195329804487
- González-González, N.L., González Dávila, E., Padrón, E., Armas Gonzalez, M. & Plasencia, W. (2018). Value of Placental Volume and Vascular Flow Indices as Predictors of Early and Late Preeclampsia at First Trimester. Fetal. Diagn. Ther., DOI: 10.1159/00048143329393218
- Porto, L.B., Brandão, A.H.F., Leite, H.V. & Cabral, A.C.V. (2017). Longitudinal evaluation of uterine perfusion, endothelial function and central blood flow in early onset pre-eclampsia. Pregnancy. Hypertens., 10, 161–64.10.1016/j.preghy.2017.08.00529153671
- Navaratnam, K., Abreu, P., Clarke, H., Jorgensen, A., Alfirevic, A. & Alfirevic, Z. (2017). Evaluation of agreement of placental growth factor (PlGF) tests and the soluble FMS-like tyrosine kinase 1 (sFlt-1)/PlGF ratio, comparison of predictive accuracy for pre-eclampsia, and relation to uterine artery Doppler and response to aspirin. J. Matern. Fetal. Neonatal. Med., DOI: 10.1080/14767058.2017.1373760.28851242
- Lee, R.C., Feinbaum, R.L. & Ambros, V. (1993). The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell., 75(5), 843–54.10.1016/0092-8674(93)90529-Y
- Mens, M.M.J. & Ghanbari, M. (2018). Cell Cycle Regulation of Stem Cells by MicroRNAs. Stem. Cell. Rev., 14(3), 309–22.10.1007/s12015-018-9808-y
- Soltanzadeh-Yamchi, M., Shahbazi, M., Aslani, S. & Mohammadnia-Afrouzi, M. (2018). MicroRNA signature of regulatory T cells in health and autoimmunity. Biomed. Pharmacother., 100, 316–23.10.1016/j.biopha.2018.02.03029453041
- Lam, I.K.Y., Chow, J.X., Lau, C.S. & Chan, V.S.F. (2018). MicroRNA-mediated immune regulation in rheumatic diseases. Cancer. Lett., 431, 201–12.10.1016/j.canlet.2018.05.04429859876
- Bhaskaran, M. & Mohan, M. (2014). MicroRNAs: history, biogenesis, and their evolving role in animal development and disease. Vet. Pathol., 51(4), 759–74.2404589010.1177/0300985813502820
- Lou, W., Liu, J., Gao, Y., Zhong, G., Chen, D., Shen, J., Bao, C., Xu, L., Pan, J., Cheng, J., Ding, B. & Fan, W. (2017). MicroRNAs in cancer metastasis and angiogenesis. Oncotarget., 8(70), 115787–802.29383201
- Data available on miRBase: the microRNA database
http://www.mirbase.org/cgi-bin/browse.pl?org=hsa Data retracted on July 10th 2018. - Pineles, B.L., Romero, R., Montenegro, D., Tarca, A.L., Han, Y.M., Kim, Y.M., Draghici, S., Espinoza, J., Kusanovic, J.P., Mittal, P., Hassan, S.S. & Kim, C.J. (2007). Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with pre-eclampsia. Am. J. Obstet. Gynecol., 196(3), 261.e1–6.10.1016/j.ajog.2007.01.008
- Zhang, Y., Diao, Z., Su, L., Sun, H., Li, R., Cui, H. & Hu, Y. (2010). MicroRNA-155 contributes to preeclampsia by down-regulating CYR61. Am. J. Obstet. Gynecol., 202(5), 466.e1–7.10.1016/j.ajog.2010.01.057
- Gellhaus, A., Schmidt, M., Dunk, C., Lye, S.J., Kimmig, R. & Winterhager, E. (2006). Decreased expression of the angiogenic regulators CYR61 (CCN1) and NOV (CCN3) in human placenta is associated with pre-eclampsia. Mol. Hum. Reprod., 12(6), 389–99.1667554510.1093/molehr/gal044
- Dai, Y., Diao, Z., Sun, H., Li, R., Qiu, Z. & Hu, Y. (2011). MicroRNA-155 is involved in the remodelling of human-trophoblast-derived HTR-8/SVneo cells induced by lipopolysaccharides. Hum. Reprod., 26(7), 1882–91.10.1093/humrep/der11821515911
- Enquobahrie, D.A., Abetew, D.F., Sorensen, T.K., Willoughby, D., Chidambaram, K. & Williams, M.A. (2011). Placental microRNA expression in pregnancies complicated by preeclampsia. Am. J. Obstet. Gynecol., 204(2), 178.e12–21.10.1016/j.ajog.2010.09.004
- Muralimanoharan, S., Maloyan, A., Mele, J., Guo, C., Myatt, L.G. & Myatt, L. (2012). MIR-210 modulates mitochondrial respiration in placenta with preeclampsia. Placenta., 33(10), 816–23.2284029710.1016/j.placenta.2012.07.002
- Gunel, T., Zeybek, Y.G., Akçakaya, P., Kalelioğlu, I., Benian, A., Ermis, H. & Aydınlı, K. (2011). Serum microRNA expression in pregnancies with preeclampsia. Genet. Mol. Res., 10(4), 4034–40.10.4238/2011.November.8.522095477
- Shen, L., Li, Y., Li, R., Diao, Z., Yany, M., Wu, M., Sun, H., Yan, G. & Hu Y. (2018). Placenta-associated serum exosomal miR-155 derived from patients with preeclampsia inhibits eNOS expression in human umbilical vein endothelial cells. Int. J. Mol. Med., 41(3), 1731–1739.
- Winger, E.E., Reed, J.L., Ji, X. & Nicolaides, K. (2018). Peripheral blood cell microRNA quantification during the first trimester predicts preeclampsia: Proof of concept. PLoS One., 13(1), e0190654.29293682
- Luque, A., Farwati, A., Crovetto, F., Crispi, F., Figueras, F., Gratacós, E. & Aran, J.M. (2014). Usefulness of circulating microRNAs for the prediction of early preeclampsia at first-trimester of pregnancy. Sci. Rep., 4, 4882.24811064
- Ngene, N.C. & Moodley, J. (2018). Role of angiogenic factors in the pathogenesis and management of preeclampsia. Int. J. Gynaecol. Obstet., 141(1), 5–13.2922293810.1002/ijgo.12424
- Bates, D.O., Beazley-Long, N., Benest, A.V., Ye, X., Ved, N., Hulse, R.P., Barratt, S., Machado, M.J., Donaldson, L.F., Harper, S.J., Peiris-Pages, M., Tortonese, D.J., Oltean, S. & Foster, R.R. (2018). Physiological Role of Vascular Endothelial Growth Factors as Homeostatic Regulators. Compr. Physiol., 8(3), 955–979.29978898
- Powe, C.E., Levine, R.J. & Karumanchi, S.A. (2011). Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation., 123(24),21690502
- Chau, K., Hennessy, A. & Makris, A. (2017). Placental growth factor and pre-eclampsia. J. Hum. Hypertens., 31(12), 782–786.2911529410.1038/jhh.2017.61
- Abou El Hassan, M., Diamandis, E.P., Karumanchi, S.A., Shennan, A.H. & Taylor, R.N. (2015). Preeclampsia: an old disease with new tools for better diagnosis and risk management. Clin. Chem., 61(5), 694–8.10.1373/clinchem.2014.23056525614469
- Weissgerber, T.L., Rajakumar, A., Myerski, A.C., Edmunds, L.R., Powers, R.W., Roberts, J.M., Gandley, R.E. & Hubel, C.A. (2014). Vascular pool of releasable soluble VEGF receptor-1 (sFLT1) in women with previous preeclampsia and uncomplicated pregnancy. J. Clin. Endocrinol. Metab., 99(3), 978–87.10.1210/jc.2013-327724423299
- Palmer, K.R., Tong, S. & Kaitu’u-Lino, T.J. (2017). Placental-specific sFLT-1: role in pre-eclamptic pathophysiology and its translational possibilities for clinical prediction and diagnosis. Mol. Hum. Reprod., 23(2), 69–78.27986932
- Gregory, A.L., Xu, G., Sotov, V. & Letarte, M. (2014). Review: the enigmatic role of endoglin in the placenta. Placenta., 35 Suppl, S93–9.10.1016/j.placenta.2013.10.02024252708
- Cheifetz, S., Bellon, T., Cales, C., Vera, S., Bernabeu, C., Massague, J. & Letarte, M. (1992). Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J. Biol. Chem., 267(27), 19027e30.1326540
- Toporsian, M., Gros, R., Kabir, M.G., Vera, S., Govindaraju, K., Eidelman, D.H., Husain, M. & Letarte, M. (2005). A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia. Circ. Res., 96(6), 684e92.15718503
- Li, C.G., Wilson, P.B., Bernabeu, C., Raab, U., Wang, J.M. & Kumar, S. (1998). Immunodetection and characterization of soluble CD105-TGF-ß complexes. J. Immunol. Methods., 218, 85e93.9819125
- Jardim, L.L., Rios, D.R., Perucci, L.O., de Sousa, L.P., Gomes, K.B. & Dusse, L.M. (2015). Is the imbalance between pro-angiogenic and anti-angiogenic factors associated with preeclampsia? Clin. Chim. Acta., 447, 34–8.2598278110.1016/j.cca.2015.05.004
- David, L., Mallet, C., Mazerbourg, S., Feige, J.J. & Bailly, S. (2007). Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. Blood., 109(5), 1953e61.17068149
- Possomato-Vieira, J.S. & Khalil, R.A. (2016). Mechanisms of Endothelial Dysfunction in Hypertensive Pregnancy and Preeclampsia. Adv Pharmacol., 77, 361–431.10.1016/bs.apha.2016.04.00827451103
- Tarasevičienė, V., Grybauskienė, R. & Mačiulevičienė, R. (2016). sFlt-1, PlGF, sFlt-1/PlGF ratio and uterine artery Doppler for preeclampsia diagnostics. Medicina. (Kaunas)., 52(6), 349–353.10.1016/j.medici.2016.11.00827940029
- Benovská, M., Opluštilová, A., Pinkavová, J., Hodická, Z. & Cermáková, Z. (2018). The New Possibilities in Early Diagnosis of Preeclampsia by Soluble fms-Like Tyrosine Kinase-1 and Placental Growth Factor in 16–20 Weeks Gestation. Lab. Med., 49(2), 112–117.10.1093/labmed/lmx07629267975
- Caillon, H., Tardif, C., Dumontet, E., Winer, N. & Masson, D. (2018). Evaluation of sFlt-1/PlGF Ratio for Predicting and Improving Clinical Management of Preeclampsia: Experience in a Specialized Perinatal Care Center. Ann. Lab. Med., 38(2), 95–101.10.3343/alm.2018.38.2.95
- AbdelHalim, R.M., Ramadan, D.I., Zeyada, R., Nasr, A.S. & Mandour, I.A. (2016). Circulating Maternal Total Cell-Free DNA, Cell-Free Fetal DNA and Soluble Endoglin Levels in Preeclampsia: Predictors of Adverse Fetal Outcome? A Cohort Study. Mol. Diagn. Ther., 20(2), 135–49.10.1007/s40291-015-0184-x26790664
- Allen, R.E., Rogozinska, E., Cleverly, K., Aquilina, J. & Thangaratinam, S. (2014). Abnormal blood biomarkers in early pregnancy are associated with preeclampsia: a meta-analysis. Eur. J. Obstet. Gynecol. Reprod. Biol., 182, 194–201.2530566210.1016/j.ejogrb.2014.09.027
- Moore Simas, T.A., Crawford, S.L., Bathgate, S., Yan, J., Robidoux, L., Moore, M. & Maynard, S.E. (2014). Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women. J. Matern. Fetal. Neonatal. Med., 27(10), 1038–48.10.3109/14767058.2013.84741524066977